tooluniverse-protein-structure-retrieval
Retrieves protein structure data from RCSB PDB, PDBe, and AlphaFold with protein disambiguation, quality assessment, and comprehensive structural profiles. Creates detailed structure reports with experimental metadata, ligand information, and download links. Use when users need protein structures, 3D models, crystallography data, or mention PDB IDs (4-character codes like 1ABC) or UniProt accessions.
Best use case
tooluniverse-protein-structure-retrieval is best used when you need a repeatable AI agent workflow instead of a one-off prompt.
Retrieves protein structure data from RCSB PDB, PDBe, and AlphaFold with protein disambiguation, quality assessment, and comprehensive structural profiles. Creates detailed structure reports with experimental metadata, ligand information, and download links. Use when users need protein structures, 3D models, crystallography data, or mention PDB IDs (4-character codes like 1ABC) or UniProt accessions.
Teams using tooluniverse-protein-structure-retrieval should expect a more consistent output, faster repeated execution, less prompt rewriting.
When to use this skill
- You want a reusable workflow that can be run more than once with consistent structure.
When not to use this skill
- You only need a quick one-off answer and do not need a reusable workflow.
- You cannot install or maintain the underlying files, dependencies, or repository context.
Installation
Claude Code / Cursor / Codex
Manual Installation
- Download SKILL.md from GitHub
- Place it in
.claude/skills/tooluniverse-protein-structure-retrieval/SKILL.mdinside your project - Restart your AI agent — it will auto-discover the skill
How tooluniverse-protein-structure-retrieval Compares
| Feature / Agent | tooluniverse-protein-structure-retrieval | Standard Approach |
|---|---|---|
| Platform Support | Not specified | Limited / Varies |
| Context Awareness | High | Baseline |
| Installation Complexity | Unknown | N/A |
Frequently Asked Questions
What does this skill do?
Retrieves protein structure data from RCSB PDB, PDBe, and AlphaFold with protein disambiguation, quality assessment, and comprehensive structural profiles. Creates detailed structure reports with experimental metadata, ligand information, and download links. Use when users need protein structures, 3D models, crystallography data, or mention PDB IDs (4-character codes like 1ABC) or UniProt accessions.
Where can I find the source code?
You can find the source code on GitHub using the link provided at the top of the page.
SKILL.md Source
# Protein Structure Data Retrieval
Retrieve protein structures with proper disambiguation, quality assessment, and comprehensive metadata.
**IMPORTANT**: Always use English terms in tool calls (protein names, organism names), even if the user writes in another language. Only try original-language terms as a fallback if English returns no results. Respond in the user's language.
## Workflow Overview
```
Phase 0: Clarify (if needed)
↓
Phase 1: Disambiguate Protein Identity
↓
Phase 2: Retrieve Structures (Internal)
↓
Phase 3: Report Structure Profile
```
---
## Phase 0: Clarification (When Needed)
Ask the user ONLY if:
- Protein name matches multiple genes/families (e.g., "kinase" → which kinase?)
- Organism not specified for conserved proteins
- Intent unclear: need experimental structure vs AlphaFold prediction?
Skip clarification for:
- Specific PDB IDs (4-character codes)
- UniProt accessions
- Unambiguous protein names with organism
---
## Phase 1: Protein Disambiguation
### 1.1 Resolve Protein Identity
```python
from tooluniverse import ToolUniverse
tu = ToolUniverse()
tu.load_tools()
# Strategy depends on input type
if user_provided_pdb_id:
# Direct structure retrieval
pdb_id = user_provided_pdb_id.upper()
elif user_provided_uniprot:
# Get UniProt info, then search structures
uniprot_id = user_provided_uniprot
# Can also get AlphaFold structure
af_structure = tu.tools.alphafold_get_structure_by_uniprot(
uniprot_id=uniprot_id
)
elif user_provided_protein_name:
# Search by name
result = tu.tools.search_structures_by_protein_name(
protein_name=protein_name
)
```
### 1.2 Identity Resolution Checklist
- [ ] Protein name/gene identified
- [ ] Organism confirmed
- [ ] UniProt accession (if available)
- [ ] Isoform/variant specified (if relevant)
### 1.3 Handle Naming Collisions
Common ambiguous terms:
| Term | Ambiguity | Resolution |
|------|-----------|------------|
| "kinase" | Hundreds of kinases | Ask which kinase (EGFR, CDK2, etc.) |
| "receptor" | Many receptor types | Specify receptor family |
| "protease" | Multiple families | Ask serine/cysteine/metallo/etc. |
| "hemoglobin" | Clear | Proceed (α/β chain specified if needed) |
| "insulin" | Clear | Proceed |
---
## Phase 2: Data Retrieval (Internal)
Retrieve all data silently. Do NOT narrate the search process.
### 2.1 Search Structures
```python
# Search by protein name
result = tu.tools.search_structures_by_protein_name(
protein_name=protein_name
)
# Filter results by quality
high_res = [
entry for entry in result["data"]
if entry.get("resolution") and entry["resolution"] < 2.5
]
```
### 2.2 Get Structure Details
For each relevant structure:
```python
pdb_id = "4INS"
# Basic metadata
metadata = tu.tools.get_protein_metadata_by_pdb_id(pdb_id=pdb_id)
# Experimental details
exp_details = tu.tools.get_protein_experimental_details_by_pdb_id(
pdb_id=pdb_id
)
# Resolution (if X-ray)
resolution = tu.tools.get_protein_resolution_by_pdb_id(pdb_id=pdb_id)
# Bound ligands
ligands = tu.tools.get_protein_ligands_by_pdb_id(pdb_id=pdb_id)
# Similar structures
similar = tu.tools.get_similar_structures_by_pdb_id(
pdb_id=pdb_id,
cutoff=2.0
)
```
### 2.3 PDBe Additional Data
```python
# Entry summary
summary = tu.tools.pdbe_get_entry_summary(pdb_id=pdb_id)
# Molecular entities
molecules = tu.tools.pdbe_get_molecules(pdb_id=pdb_id)
# Binding sites
binding_sites = tu.tools.pdbe_get_binding_sites(pdb_id=pdb_id)
```
### 2.4 AlphaFold Predictions
```python
# When no experimental structure exists, or for comparison
if uniprot_id:
af_structure = tu.tools.alphafold_get_structure_by_uniprot(
uniprot_id=uniprot_id
)
```
### Fallback Chains
| Primary | Fallback | Notes |
|---------|----------|-------|
| RCSB search | PDBe search | Regional availability |
| get_protein_metadata | pdbe_get_entry_summary | Alternative source |
| Experimental structure | AlphaFold prediction | No experimental structure |
| get_protein_ligands | pdbe_get_binding_sites | Ligand info unavailable |
---
## Phase 3: Report Structure Profile
### Output Structure
Present as a **Structure Profile Report**. Hide search process.
```markdown
# Protein Structure Profile: [Protein Name]
**Search Summary**
- Query: [protein name/PDB ID]
- Organism: [species]
- Structures Found: [N] experimental, [M] AlphaFold
---
## Best Available Structure
### [PDB ID]: [Title]
| Attribute | Value |
|-----------|-------|
| **PDB ID** | [pdb_id] |
| **UniProt** | [uniprot_id] |
| **Organism** | [species] |
| **Method** | X-ray / Cryo-EM / NMR |
| **Resolution** | [X.XX] Å |
| **Release Date** | [date] |
**Quality Assessment**: ●●● High / ●●○ Medium / ●○○ Low
### Experimental Details
| Parameter | Value |
|-----------|-------|
| **Method** | [X-ray crystallography] |
| **Resolution** | [1.9 Å] |
| **R-factor** | [0.18] |
| **R-free** | [0.21] |
| **Space Group** | [P 21 21 21] |
### Structure Composition
| Component | Count | Details |
|-----------|-------|---------|
| **Chains** | [N] | [A (enzyme), B (inhibitor)] |
| **Residues** | [N] | [coverage %] |
| **Ligands** | [N] | [list ligand names] |
| **Waters** | [N] | |
| **Metals** | [N] | [Zn, Mg, etc.] |
### Bound Ligands
| Ligand ID | Name | Type | Binding Site |
|-----------|------|------|--------------|
| [ATP] | Adenosine triphosphate | Substrate | Active site |
| [MG] | Magnesium ion | Cofactor | Catalytic |
### Binding Site Details
For drug discovery applications:
**Site 1: Active Site**
- Location: Chain A, residues 45-89
- Key residues: Asp45, Glu67, His89
- Pocket volume: [X] ų
- Druggability: High/Medium/Low
---
## Alternative Structures
Ranked by quality and relevance:
| Rank | PDB ID | Resolution | Method | Ligands | Notes |
|------|--------|------------|--------|---------|-------|
| 1 | [4INS] | 1.9 Å | X-ray | Zn | Best resolution |
| 2 | [3I40] | 2.1 Å | X-ray | Zn, phenol | With inhibitor |
| 3 | [1TRZ] | 2.3 Å | X-ray | None | Porcine |
---
## AlphaFold Prediction
### AF-[UniProt]-F1
| Attribute | Value |
|-----------|-------|
| **UniProt** | [uniprot_id] |
| **Model Version** | [v4] |
| **Confidence (pLDDT)** | [average score] |
**Confidence Distribution**:
- Very High (>90): [X]% of residues
- High (70-90): [X]% of residues
- Low (50-70): [X]% of residues
- Very Low (<50): [X]% of residues
**Use Cases**:
- ✓ Overall fold reliable
- ✓ Core domain structure
- ⚠ Loop regions uncertain
- ✗ Not suitable for binding site analysis
---
## Structure Comparison
| Property | [PDB_1] | [PDB_2] | AlphaFold |
|----------|---------|---------|-----------|
| Resolution | 1.9 Å | 2.5 Å | N/A (predicted) |
| Completeness | 98% | 85% | 100% |
| Ligands | Yes | No | No |
| Confidence | Experimental | Experimental | High (85 avg) |
---
## Download Links
### Coordinate Files
| Format | PDB ID | Link |
|--------|--------|------|
| PDB | [4INS] | [link] |
| mmCIF | [4INS] | [link] |
| AlphaFold | [UniProt] | [link] |
### Database Links
- RCSB PDB: https://www.rcsb.org/structure/[pdb_id]
- PDBe: https://www.ebi.ac.uk/pdbe/entry/pdb/[pdb_id]
- AlphaFold: https://alphafold.ebi.ac.uk/entry/[uniprot_id]
Retrieved: [date]
```
---
## Quality Assessment Tiers
### Experimental Structures
| Tier | Symbol | Criteria |
|------|--------|----------|
| Excellent | ●●●● | X-ray <1.5Å, complete, R-free <0.22 |
| High | ●●●○ | X-ray <2.0Å OR Cryo-EM <3.0Å |
| Good | ●●○○ | X-ray 2.0-3.0Å OR Cryo-EM 3.0-4.0Å |
| Moderate | ●○○○ | X-ray >3.0Å OR NMR ensemble |
| Low | ○○○○ | >4.0Å, incomplete, or problematic |
### Resolution Guide
| Resolution | Use Case |
|------------|----------|
| <1.5 Å | Atomic detail, H-bond analysis |
| 1.5-2.0 Å | Drug design, mechanism studies |
| 2.0-2.5 Å | Structure-based design |
| 2.5-3.5 Å | Overall architecture, fold |
| >3.5 Å | Domain arrangement only |
### AlphaFold Confidence
| pLDDT Score | Interpretation |
|-------------|----------------|
| >90 | Very high confidence, experimental-like |
| 70-90 | Good backbone confidence |
| 50-70 | Uncertain, flexible regions |
| <50 | Low confidence, likely disordered |
---
## Completeness Checklist
Every structure report MUST include:
### For Specific PDB ID (Required)
- [ ] PDB ID and title
- [ ] Experimental method
- [ ] Resolution (or N/A for NMR)
- [ ] Organism
- [ ] Quality assessment
- [ ] Download links
### For Protein Name Search (Required)
- [ ] Search summary with result count
- [ ] Top structures with quality ranking
- [ ] Best structure recommendation
- [ ] AlphaFold alternative (if no experimental structure)
### Always Include
- [ ] Ligand information (or "No ligands bound")
- [ ] Data sources with links
- [ ] Retrieval date
---
## Common Use Cases
### Drug Discovery Target
User: "Get structure for EGFR kinase with inhibitor"
→ Filter for ligand-bound structures, emphasize binding site
### Model Building
User: "Find best template for homology modeling of protein X"
→ High-resolution structures, note sequence coverage
### Structure Comparison
User: "Compare available SARS-CoV-2 main protease structures"
→ All structures with systematic comparison table
### AlphaFold When No Experimental
User: "Structure of protein with UniProt P12345"
→ Check PDB first, then AlphaFold, note confidence
---
## Error Handling
| Error | Response |
|-------|----------|
| "PDB ID not found" | Verify 4-character format, check if obsoleted |
| "No structures for protein" | Offer AlphaFold prediction, suggest similar proteins |
| "Download failed" | Retry once, provide alternative link |
| "Resolution unavailable" | Likely NMR/model, note in assessment |
---
## Tool Reference
**RCSB PDB (Experimental Structures)**
| Tool | Purpose |
|------|---------|
| `search_structures_by_protein_name` | Name-based search |
| `get_protein_metadata_by_pdb_id` | Basic info |
| `get_protein_experimental_details_by_pdb_id` | Method details |
| `get_protein_resolution_by_pdb_id` | Quality metric |
| `get_protein_ligands_by_pdb_id` | Bound molecules |
| `download_pdb_structure_file` | Coordinate files |
| `get_similar_structures_by_pdb_id` | Homologs |
**PDBe (European PDB)**
| Tool | Purpose |
|------|---------|
| `pdbe_get_entry_summary` | Overview |
| `pdbe_get_molecules` | Molecular entities |
| `pdbe_get_experiment_info` | Experimental data |
| `pdbe_get_binding_sites` | Ligand pockets |
**AlphaFold (Predictions)**
| Tool | Purpose |
|------|---------|
| `alphafold_get_structure_by_uniprot` | Get prediction |
| `alphafold_search_structures` | Search predictions |Related Skills
tooluniverse-target-research
Gather comprehensive biological target intelligence from 9 parallel research paths covering protein info, structure, interactions, pathways, expression, variants, drug interactions, and literature. Features collision-aware searches, evidence grading (T1-T4), explicit Open Targets coverage, and mandatory completeness auditing. Use when users ask about drug targets, proteins, genes, or need target validation, druggability assessment, or comprehensive target profiling.
tooluniverse-protein-therapeutic-design
Design novel protein therapeutics (binders, enzymes, scaffolds) using AI-guided de novo design. Uses RFdiffusion for backbone generation, ProteinMPNN for sequence design, ESMFold/AlphaFold2 for validation. Use when asked to design protein binders, therapeutic proteins, or engineer protein function.
tooluniverse-pharmacovigilance
Analyze drug safety signals from FDA adverse event reports, label warnings, and pharmacogenomic data. Calculates disproportionality measures (PRR, ROR), identifies serious adverse events, assesses pharmacogenomic risk variants. Use when asked about drug safety, adverse events, post-market surveillance, or risk-benefit assessment.
tooluniverse-network-pharmacology
Construct and analyze compound-target-disease networks for drug repurposing, polypharmacology discovery, and systems pharmacology. Builds multi-layer networks from ChEMBL, OpenTargets, STRING, DrugBank, Reactome, FAERS, and 60+ other ToolUniverse tools. Calculates Network Pharmacology Scores (0-100), identifies repurposing candidates, predicts mechanisms, and analyzes polypharmacology. Use when users ask about drug repurposing via network analysis, multi-target drug effects, compound-target-disease networks, systems pharmacology, or polypharmacology.
tooluniverse-drug-target-validation
Comprehensive computational validation of drug targets for early-stage drug discovery. Evaluates targets across 10 dimensions (disambiguation, disease association, druggability, chemical matter, clinical precedent, safety, pathway context, validation evidence, structural insights, validation roadmap) using 60+ ToolUniverse tools. Produces a quantitative Target Validation Score (0-100) with GO/NO-GO recommendation. Use when users ask about target validation, druggability assessment, target prioritization, or "is X a good drug target for Y?"
tooluniverse-drug-research
Generates comprehensive drug research reports with compound disambiguation, evidence grading, and mandatory completeness sections. Covers identity, chemistry, pharmacology, targets, clinical trials, safety, pharmacogenomics, and ADMET properties. Use when users ask about drugs, medications, therapeutics, or need drug profiling, safety assessment, or clinical development research.
tooluniverse-drug-repurposing
Identify drug repurposing candidates using ToolUniverse for target-based, compound-based, and disease-driven strategies. Searches existing drugs for new therapeutic indications by analyzing targets, bioactivity, safety profiles, and literature evidence. Use when exploring drug repurposing opportunities, finding new indications for approved drugs, or when users mention drug repositioning, off-label uses, or therapeutic alternatives.
tooluniverse-drug-drug-interaction
Comprehensive drug-drug interaction (DDI) prediction and risk assessment. Analyzes interaction mechanisms (CYP450, transporters, pharmacodynamic), severity classification, clinical evidence grading, and provides management strategies. Supports single drug pairs, polypharmacy analysis (3+ drugs), and alternative drug recommendations. Use when users ask about drug interactions, medication safety, polypharmacy risks, or need DDI assessment for clinical decision support.
tooluniverse-chemical-safety
Comprehensive chemical safety and toxicology assessment integrating ADMET-AI predictions, CTD toxicogenomics, FDA label safety data, DrugBank safety profiles, and STITCH chemical-protein interactions. Performs predictive toxicology (AMES, DILI, LD50, carcinogenicity), organ/system toxicity profiling, chemical-gene-disease relationship mapping, regulatory safety extraction, and environmental hazard assessment. Use when asked about chemical toxicity, drug safety profiling, ADMET properties, environmental health risks, chemical hazard assessment, or toxicogenomic analysis.
tooluniverse-chemical-compound-retrieval
Retrieves chemical compound information from PubChem and ChEMBL with disambiguation, cross-referencing, and quality assessment. Creates comprehensive compound profiles with identifiers, properties, bioactivity, and drug information. Use when users need chemical data, drug information, or mention PubChem CID, ChEMBL ID, SMILES, InChI, or compound names.
tooluniverse-binder-discovery
Discover novel small molecule binders for protein targets using structure-based and ligand-based approaches. Creates actionable reports with candidate compounds, ADMET profiles, and synthesis feasibility. Use when users ask to find small molecules for a target, identify novel binders, perform virtual screening, or need hit-to-lead compound identification.
tooluniverse-antibody-engineering
Comprehensive antibody engineering and optimization for therapeutic development. Covers humanization, affinity maturation, developability assessment, and immunogenicity prediction. Use when asked to optimize antibodies, humanize sequences, or engineer therapeutic antibodies from lead to clinical candidate.